Holen Sie sich die Stockscreener-App
48.87
4.56%
2.13
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CYTK?
Forum
Prognose
Aktiensplit
Finanzdaten der Cytokinetics Inc-Aktie (CYTK)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
50.06%
0.835
|
1.672 | 0.378 | 0.867 | 4.613 |
Operating Expenses
|
1.56%
127.07
|
129.09 | 122.64 | 122.92 | 129.09 |
| Interest Income/Expense |
0.85%
7.103
|
7.164 | 7.136 | 7.045 | 6.961 |
| Benefits Costs and Expenses |
1.51%
136.48
|
138.57 | - | - | 135.90 |
| Costs And Expenses |
1.51%
136.48
|
138.57 | 122.64 | 122.92 | 135.90 |
| Operating Income/Loss |
0.93%
-126.23
|
-127.42 | -122.27 | -122.05 | -124.47 |
| Nonoperating Income/Loss |
4.31%
7.913
|
7.586 | 6.839 | 6.779 | 6.425 |
| Income/Loss From Continuing Operations Before Tax |
0.92%
-135.64
|
-136.90 | 0.378 | -128.64 | -131.29 |
| Income/Loss From Continuing Operations After Tax |
0.92%
-135.64
|
-136.90 | -129.42 | -128.64 | -131.29 |
|
Net Income/Loss
|
0.92%
-135.64
|
-136.90 | -129.42 | -128.64 | -131.29 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
11,779%
0.1019
|
0.000858 | 0.0961 | 0.0958 | 0.0952 |
| Diluted Average Shares |
11,779%
0.1019
|
0.000858 | 0.0961 | 0.0958 | 0.0952 |
| Basic Earnings Per Share |
3.62%
-1.33
|
-1.38 | -1.35 | -1.34 | -1.38 |
| Diluted Earnings Per Share |
3.62%
-1.33
|
-1.38 | -1.35 | -1.34 | -1.38 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):